Lataa...
Gliptins: A New Class of Oral Antidiabetic Agents
India has the largest population of patients with type 2 diabetes mellitus. The conventional agents used to treat type 2 diabetes frequently exhibit reduced efficacy over time leading to inadequate glycaemic control and are also associated with adverse effects. Hence, there is a need for alternative...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2846464/ https://ncbi.nlm.nih.gov/pubmed/20376212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0250-474X.59541 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|